Optimizing the Use of Virtual Reality in Rehabilitation for Individuals With Persistent Shoulder Pain
1 other identifier
interventional
30
1 country
1
Brief Summary
The primary objective of this clinical trial is to investigate the effect of a block of four specific virtual reality (VR) exercises on upper limb function, pain, kinesiophobia, and pain catastrophizing in individuals with rotator cuff-related shoulder pain (RCRSP). The secondary objective is to examine participants' tolerability of different VR interventions. Study Procedures: Participants will:
- Attend a face-to-face assessment to confirm eligibility and receive a standardized pain neurophysiology education session (week 0).
- Visit the clinic once weekly for four weeks to undergo the VR interventions and review pain education concepts (Weeks 5 to 8).
- Complete online questionnaires evaluating upper limb function, kinesiophobia, pain, sense of presence, and cybersickness. Interventions Four VR interventions will be tested:
- Unimanual distraction task with normal visual feedback
- Bimanual distraction task with normal visual feedback
- Unimanual reaching task with augmented visual feedback
- Unimanual reaching task with diminished visual feedback Findings will guide clinicians in selecting the most effective VR interventions for shoulder impairment and assess the feasibility of implementing VR in a private physiotherapy clinic for individuals with RCRSP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedStudy Start
First participant enrolled
January 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 19, 2025
December 1, 2025
12 months
December 7, 2025
December 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptoms and functional limitations specific to the upper limbs
The QuickDASH is an 11-item questionnaire, validated in individuals with rotator cuff-related shoulder pain, addressing the level of difficulty in performing daily activities and the severity of the symptoms of the upper limbs. Higher scores indicate greater pain and functional limitations.
post-intervention (week 8)
Secondary Outcomes (21)
Symptoms and functional limitations specific to the upper limbs
baseline
Symptoms and functional limitations specific to the upper limbs
pre-intervention (week 4)
Functional limitations
baseline
Functional limitations
pre-intervention (week 4)
Functional limitations
post-intervention (week 8)
- +16 more secondary outcomes
Study Arms (1)
Virtual reality interventions
EXPERIMENTALAll participants will complete a four-week intervention, performing one of the four types of virtual reality (VR) exercises per week, so that each participant experiences all four exercises: 1. Unimanual distraction task with normal visual feedback 2. Bimanual distraction task with normal visual feedback 3. Unimanual reaching task with augmented visual feedback 4. Unimanual reaching task with diminished visual feedback During each session, participants will reach 18 targets positioned at heights of 60°, 90°, and 120° across three planes of motion (flexion, scaption, and abduction). Target positions will be adjusted to accommodate each participant's arm length and size. To ensure participant comfort, the session will end if repetitions are not completed within 2 minutes. The order of interventions will be randomized for each participant.
Interventions
Bimanual tasks with unaltered visual feedback (targets positioned based on the affected limb) will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to adjust task difficulty.
Unimanual tasks (performed with the affected limb) with unaltered visual feedback will involve distraction exercises in which participants move a tray toward targets while keeping a ball balanced on the tray. Three trials with varying levels of friction between the ball and tray will be presented to manipulate the task's difficulty.
Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 25%, or 50% amplification of movement in the virtual environment compared to the real world. While virtual targets will appear farther apart, the actual movement required to reach them will remain the same across all trials.
Three trials with varying levels of visual feedback alteration will be performed, corresponding to a 0%, 17%, or 33% reduction in movement in the virtual environment compared to the real world. Although the virtual targets will appear closer together, the actual movement required to reach them will remain the same across all trials.
Eligibility Criteria
You may qualify if:
- Rotator cuff-related shoulder pain (screen by phone and then confirmed by the physiotherapist at the initial evaluation: pain over the deltoid and/or upper arm region, pain associated with arm movement \[painful arc of movement\], and familiar pain reproduced with loading or resisted testing during external rotation of the arm) for at least 6 months
- Minimum score of 15/100 on the shortened version of the Disabilities of the Arm, Shoulder, and Hand (1.5 times the minimally clinically important difference)
You may not qualify if:
- Unavailable for the 4 weeks intervention
- Cannot understand or read French
- Have a diagnosis of rheumatoid, inflammatory or neurodegenerative diseases
- Have received a corticosteroid injection or any other type of injection (e.g., platelet-rich plasma, prolotherapy, hyaluronic acid) in the past three months for their current condition
- Have bilateral shoulder pain
- Have pain in another upper limb joint
- Have signs of upper (e.g., bilateral paresthesia, hyperreflexia, or spasticity) or lower (e.g., decreased sensation or strength in dermatomes and myotomes, hypotonia, or hyporeflexia) motor neuron lesions
- History of shoulder surgery, dislocation, or fracture
- Presence of severe osteoarthritis, symptomatic acromioclavicular joint pathology, or adhesive capsulitis (defined as restriction of passive glenohumeral movement of at least 30% for two or more directions)
- Full thickness rotator cuff tear, identified by imaging or clinical tests (lag signs and gross weakness)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
Study Sites (1)
Centre for Interdisciplinary Research in Rehabilitation and Social Integration
Québec, Quebec, G1M 2S8, Canada
MeSH Terms
Conditions
Study Officials
- STUDY DIRECTOR
Catherine Mercier, OT,PhD
Centre for Interdisciplinary Research in Rehabilitation and Social Integration (Cirris)
- STUDY DIRECTOR
Jean-Sébastien Roy, PT, PhD
Centre for Interdisciplinary Research in Rehabilitation and Social Integration (Cirris)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Participants will be blinded to the specific VR interventions they will perform to prevent anticipation or adjustment of their movements based on the intervention. For instance, they will not know whether their movements will be amplified or diminished compared to real-life motion.
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
December 7, 2025
First Posted
December 19, 2025
Study Start
January 15, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 19, 2025
Record last verified: 2025-12